Key Takeaways Labcorp acquired BioReference Health assets to strengthen its oncology diagnostics portfolio. The $225M deal includes $192.5M upfront and up to $32.5M in performance-based earnout. The acquisition expands patient and physician access to Labcorp's oncology testing services. Labcorp (LH) recently completed the acquisition of select assets of BioReference Health, a wholly owned subsidiary of OPKO Health, Inc. (OPK) , a multinational biopharmaceutical and diagnostics company. This acquisition stre ...